Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does METOPROLOL Cause Red cell distribution width increased? 23 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 23 reports of Red cell distribution width increased have been filed in association with METOPROLOL (metoprolol succinate). This represents 0.1% of all adverse event reports for METOPROLOL.

23
Reports of Red cell distribution width increased with METOPROLOL
0.1%
of all METOPROLOL reports
4
Deaths
9
Hospitalizations

How Dangerous Is Red cell distribution width increased From METOPROLOL?

Of the 23 reports, 4 (17.4%) resulted in death, 9 (39.1%) required hospitalization.

Is Red cell distribution width increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for METOPROLOL. However, 23 reports have been filed with the FAERS database.

What Other Side Effects Does METOPROLOL Cause?

Drug ineffective (3,434) Dyspnoea (3,428) Dizziness (3,275) Hypotension (3,213) Completed suicide (2,959) Fatigue (2,784) Off label use (2,580) Toxicity to various agents (2,404) Bradycardia (2,024) Nausea (1,894)

What Other Drugs Cause Red cell distribution width increased?

CLOZAPINE (439) METHOTREXATE (210) ALEMTUZUMAB (202) RITUXIMAB (198) PREDNISONE (178) PALBOCICLIB (171) ADALIMUMAB (144) METHYLPREDNISOLONE (123) ECULIZUMAB (110) TOCILIZUMAB (108)

Which METOPROLOL Alternatives Have Lower Red cell distribution width increased Risk?

METOPROLOL vs METRELEPTIN METOPROLOL vs METRONIDAZOLE METOPROLOL vs METRONIDAZOLE\METRONIDAZOLE METOPROLOL vs METYRAPONE METOPROLOL vs MEXILETINE

Related Pages

METOPROLOL Full Profile All Red cell distribution width increased Reports All Drugs Causing Red cell distribution width increased METOPROLOL Demographics